Eureka Therapeutics' Series C - II Round

Eureka Therapeutics raised a round of funding on May 30, 2017.

Eureka Therapeutics is focused on the discovery of fully-human antibody drugs for the treatment of cancer. Utilizing its antibody drug discovery and engineering technologies, Eureka is advancing safe …

Articles about Eureka Therapeutics' Series C - II Round: